Short-acting GLP-1 medications (exenatide immediate-release, lixisenatide) must be administered within 60 minutes before meals for optimal post-prandial glucose control
These forms likely have extremely poor bioavailability There are major differences between branded oral GLP-1s like Rybelsus (which use specific billion-dollar absorption tech) while these compounded versions rely on unproven or untested technology Some (not all) telehealth companies market these as equivalent to injectables, which should raise a massive red flag Follow along for more info on these topics, because people living with obesity are being taken advantage of all over again
Moreover, possible applications in protection from infections and anti-aging properties are discussed
Rotate between the left and right sides of your abdomen, thighs, and upper arms on a consistent schedule
Ro: Program features compared Both Noom and Ro provide access to GLP-1 medications for eligible people, but the programs differ in structure, guidance, and ongoing support
Here is the honest answer
